PT3087086T - Formas cristalinas de um tripéptido inibidor de hcv ns3 macrocíclico - Google Patents

Formas cristalinas de um tripéptido inibidor de hcv ns3 macrocíclico

Info

Publication number
PT3087086T
PT3087086T PT14824322T PT14824322T PT3087086T PT 3087086 T PT3087086 T PT 3087086T PT 14824322 T PT14824322 T PT 14824322T PT 14824322 T PT14824322 T PT 14824322T PT 3087086 T PT3087086 T PT 3087086T
Authority
PT
Portugal
Prior art keywords
crystalline forms
macrocyclic hcv
tripeptide
inhibiting
inhibiting tripeptide
Prior art date
Application number
PT14824322T
Other languages
English (en)
Inventor
Bringley Dustin
Chan Johann
Fung Peter
Keaton Katie
Lapina Olga
Morrison Henry
Pcion Dominika
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Publication of PT3087086T publication Critical patent/PT3087086T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
PT14824322T 2013-12-23 2014-12-18 Formas cristalinas de um tripéptido inibidor de hcv ns3 macrocíclico PT3087086T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361920427P 2013-12-23 2013-12-23

Publications (1)

Publication Number Publication Date
PT3087086T true PT3087086T (pt) 2019-02-06

Family

ID=52282995

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14824322T PT3087086T (pt) 2013-12-23 2014-12-18 Formas cristalinas de um tripéptido inibidor de hcv ns3 macrocíclico

Country Status (12)

Country Link
US (2) US9562058B2 (pt)
EP (1) EP3087086B1 (pt)
JP (2) JP6568541B2 (pt)
AR (1) AR098958A1 (pt)
AU (1) AU2014370124A1 (pt)
CA (1) CA2934049A1 (pt)
ES (1) ES2708993T3 (pt)
NZ (1) NZ720887A (pt)
PT (1) PT3087086T (pt)
TW (1) TW201609752A (pt)
UY (1) UY35918A (pt)
WO (1) WO2015100144A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111320610B (zh) 2013-12-23 2023-06-06 吉利德科学公司 大环hcv ns3抑制三肽的合成
RS62434B1 (sr) 2014-12-26 2021-11-30 Univ Emory Antivirusni n4-hidroksicitidin derivati
BR102017011025A2 (pt) 2016-06-02 2017-12-19 Gilead Pharmasset Llc Formulation of combination of three antiviral compounds
CN111372592A (zh) 2017-12-07 2020-07-03 埃默里大学 N4-羟基胞苷及衍生物和与其相关的抗病毒用途
CN115417803B (zh) * 2022-08-30 2023-10-03 四川同晟生物医药有限公司 乌帕替尼中间体(3r,4s)-1-苄氧羰基-4-乙基吡咯烷-3-羧酸的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
CL2008003384A1 (es) * 2007-11-14 2009-12-11 Enanta Pharm Inc Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c.
ES2491090T3 (es) * 2008-07-22 2014-09-05 Merck Sharp & Dohme Corp. Combinaciones de un compuesto de quinoxalina macrocíclica que es un inhibidor de la proteasa NS3 del VHC con otros agentes del VHC
NZ608720A (en) * 2010-09-21 2015-03-27 Enanta Pharm Inc Macrocyclic proline derived hcv serine protease inhibitors
EP2618665A4 (en) * 2010-09-21 2014-08-20 Merck Sharp & Dohme HCV NS3 PROTEASE INHIBITORS
PL3431477T3 (pl) 2011-11-16 2021-04-06 Gilead Pharmasset Llc Skondensowane imidazoliloimidazole jako związki przeciwwirusowe
UA119315C2 (uk) * 2012-07-03 2019-06-10 Гіліад Фармассет Елелсі Інгібітори вірусу гепатиту с

Also Published As

Publication number Publication date
US9862728B2 (en) 2018-01-09
AU2014370124A1 (en) 2016-06-23
JP6568541B2 (ja) 2019-08-28
AR098958A1 (es) 2016-06-22
ES2708993T3 (es) 2019-04-12
UY35918A (es) 2015-05-29
CA2934049A1 (en) 2015-07-02
US9562058B2 (en) 2017-02-07
JP2017503016A (ja) 2017-01-26
WO2015100144A1 (en) 2015-07-02
EP3087086B1 (en) 2018-11-07
US20170267694A1 (en) 2017-09-21
EP3087086A1 (en) 2016-11-02
NZ720887A (en) 2018-01-26
US20150175625A1 (en) 2015-06-25
TW201609752A (zh) 2016-03-16
JP2019089819A (ja) 2019-06-13

Similar Documents

Publication Publication Date Title
HK1222401A1 (zh) 大環 抑制三肽的合成
HK1255872A1 (zh) Hcv聚合酶抑制劑
HUS1700039I1 (hu) Makrociklusos prolinból leszármaztatható HCV szerin proteáz inhibitorok
IL235645A0 (en) Antiviral compounds inhibit hcv ns5b
EP2780026A4 (en) INHIBITORS OF HCV NS3 PROTEASE
EP2575866A4 (en) HCV NS5A INHIBITORS
EP2575475A4 (en) HCV NS5A INHIBITORS
HK1176938A1 (en) 4 - azido - nucleosides as anti - hcv compunds hcv 4--
EP2618665A4 (en) HCV NS3 PROTEASE INHIBITORS
EP2740734A4 (en) HCV Protease Inhibitors
EP2802574A4 (en) INHIBITORS OF HCV NS3 PROTEASE
HK1200847A1 (en) Inhibitors of hcv ns5a hcv ns5a
PT3087086T (pt) Formas cristalinas de um tripéptido inibidor de hcv ns3 macrocíclico
PL2729014T3 (pl) Maskowanie goryczy
HK1206747A1 (en) Crystalline forms of an hcv inhibitor hcv
HK1218959A1 (zh) 雷帕霉素衍生物的純化
EP2982088A4 (en) GROSSIÈRE SYNCHRONIZATION
EP2730176A4 (en) PEPTIDE FOR IMPROVING TASTE
IL233550A0 (en) Stable pharmaceutical formulations of an effective hepatitis c virus inhibitor
GB201319580D0 (en) HCV genotyping algorithm
GB201322292D0 (en) Plasma FET-based clock recovery
GB201105778D0 (en) Knitted glove